Edex Live on MSN
GATE 2027 DA preparation: Three-year question paper analysis reveals high-weightage topics and study priorities
Candidates preparing for the GATE 2027 Data Science and Artificial Intelligence (DA) paper can use the previous three ...
Google's EnvHarness and EnvRigger reshape static environments around an agent's diagnosed flaws, beating domain-specific ...
Box ManipulationIn the history of artificial intelligence and machine learning, the determination of internal parameters ...
A 450-task benchmark built from real CVEs shows even the best AI coding agent writes code that's both working and secure only ...
GPT-6 Astra edited Qwen’s weights and raised MATH-500 from 7.9% to 48.1% in author-run tests. How weight-space programming works—and its limits.
Even if you know the concept of AI agents, there are still few people who can actually build them. In this article, through an "AI Agent Hands-On," I will explain the specific steps and know-how for ...
Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...
For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results